Clinical Trial Update: Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the long-term efficacy of a 4- to 6-month antiviral therapy for neurodevelopmental impairments caused by congenital cytomegalo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Snippet

Sponsor: Hu Bofei | Conditions: Congenital CMV Infection | Phase 4 | Status: NOT_YET_RECRUITING